These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 31868130

  • 21. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A, Micello MF, Panza F, Fortunato F, Baricich A, Cisari C, Pilotto A, Logroscino G, Fiore P, Ranieri M.
    J Neurol Sci; 2014 Dec 15; 347(1-2):39-43. PubMed ID: 25263601
    [Abstract] [Full Text] [Related]

  • 22. Upper Limb Motor Function Affects the Outcome after Treatment with Botulinum Toxin A.
    Fujimura K, Kagaya H, Onaka H, Nagasawa N, Ishihara A, Okochi Y, Yamada M, Tanikawa H, Kanada Y, Saitoh E.
    Eur Neurol; 2019 Dec 15; 81(1-2):30-36. PubMed ID: 31013501
    [Abstract] [Full Text] [Related]

  • 23. Effects of botulinum toxin A therapy and multidisciplinary rehabilitation on lower limb spasticity classified by spastic muscle echo intensity in post-stroke patients.
    Hara T, Abo M, Hara H, Kobayashi K, Shimamoto Y, Shibata Y, Sasaki N, Yamada N, Niimi M.
    Int J Neurosci; 2018 May 15; 128(5):412-420. PubMed ID: 28985683
    [Abstract] [Full Text] [Related]

  • 24. Does botulinum toxin type A decrease pain and lessen disability in hemiplegic survivors of stroke with shoulder pain and spasticity?: a randomized, double-blind, placebo-controlled trial.
    Marciniak CM, Harvey RL, Gagnon CM, Duraski SA, Denby FA, McCarty S, Bravi LA, Polo KM, Fierstein KM.
    Am J Phys Med Rehabil; 2012 Dec 15; 91(12):1007-19. PubMed ID: 23064478
    [Abstract] [Full Text] [Related]

  • 25. Combined therapy using botulinum toxin A and single-joint hybrid assistive limb for upper-limb disability due to spastic hemiplegia.
    Saita K, Morishita T, Hyakutake K, Fukuda H, Shiota E, Sankai Y, Inoue T.
    J Neurol Sci; 2017 Feb 15; 373():182-187. PubMed ID: 28131185
    [Abstract] [Full Text] [Related]

  • 26. Dynamic Lycra® orthoses as an adjunct to arm rehabilitation after stroke: a single-blind, two-arm parallel group, randomized controlled feasibility trial.
    Morris JH, John A, Wedderburn L, Rauchhaus P, Donnan PT.
    Clin Rehabil; 2019 Aug 15; 33(8):1331-1343. PubMed ID: 30977382
    [Abstract] [Full Text] [Related]

  • 27. Local muscle injection of botulinum toxin type a synergistically improves the beneficial effects of repetitive transcranial magnetic stimulation and intensive occupational therapy in post-stroke patients with spastic upper limb hemiparesis.
    Yamada N, Kakuda W, Kondo T, Mitani S, Shimizu M, Abo M.
    Eur Neurol; 2014 Aug 15; 72(5-6):290-8. PubMed ID: 25323412
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Rehabilitation plus OnabotulinumtoxinA Improves Motor Function over OnabotulinumtoxinA Alone in Post-Stroke Upper Limb Spasticity: A Single-Blind, Randomized Trial.
    Devier D, Harnar J, Lopez L, Brashear A, Graham G.
    Toxins (Basel); 2017 Jul 11; 9(7):. PubMed ID: 28696373
    [Abstract] [Full Text] [Related]

  • 32. Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity.
    Baguley IJ, Nott MT, Turner-Stokes L, De Graaff S, Katrak P, McCrory P, de Abadal M, Hughes A.
    J Rehabil Med; 2011 Nov 11; 43(11):1032-7. PubMed ID: 22031350
    [Abstract] [Full Text] [Related]

  • 33. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial.
    Nam HS, Park YG, Paik NJ, Oh BM, Chun MH, Yang HE, Kim DH, Yi Y, Seo HG, Kim KD, Chang MC, Ryu JH, Lee SU.
    J Neurol Sci; 2015 Oct 15; 357(1-2):192-7. PubMed ID: 26233808
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD, Vuadens P, van Wijck FM, Stark S, Johnson GR, Barnes MP.
    Clin Rehabil; 2002 Sep 15; 16(6):654-60. PubMed ID: 12392341
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Extracorporeal Shock Waves Versus Botulinum Toxin Type A in the Treatment of Poststroke Upper Limb Spasticity: A Randomized Noninferiority Trial.
    Wu YT, Yu HK, Chen LR, Chang CN, Chen YM, Hu GC.
    Arch Phys Med Rehabil; 2018 Nov 15; 99(11):2143-2150. PubMed ID: 30392753
    [Abstract] [Full Text] [Related]

  • 39. Effect of adding upper limb rehabilitation to botulinum toxin-A on upper limb activity after stroke: Protocol for the InTENSE trial.
    Lannin NA, Ada L, English C, Ratcliffe J, Crotty M.
    Int J Stroke; 2018 Aug 15; 13(6):648-653. PubMed ID: 29553309
    [Abstract] [Full Text] [Related]

  • 40. Prognosis prediction of the effect of botulinum toxin therapy and intensive rehabilitation on the upper arm function in post-stroke patients using hierarchical cluster analysis.
    Hara T, Niimi M, Yamada N, Shimamoto Y, Masuda G, Hara H, Abo M.
    Disabil Rehabil; 2022 Nov 15; 44(22):6815-6823. PubMed ID: 34547217
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.